Replies to post #150002 on NorthWest Biotherapeutics Inc (NWBO)

[Ultraz2]

They are making it so hard to even consider investing here, because split, imho, is inevitable even if study positive. I have a small investment, and I just can’t watch it like many here have been doing for years.

[anders2211]

I have said my goodbye to NWBO shares already some time ago now and Im happy I did.

I calculated 1 billion shares diluted too so that checks out.

There is something that has been puzzling me. Now why would NWBO want to raise 12 million 1 month ago and 12 million again today if they only burn 1,5 million per month (and have a deal with Cognate/Advant to only per patient from here on!!). Lets do a calculation here 24 million raised (if the present share offering succeeds) -/- 5 million debt to Cognate given the last 10Q = 19 million divided by 1,5 million burning rate p/m is at least 1 more year until topline and or new dilution.

The audacity to ask for more money with present shareholders with zero info and update and having just gone from dilution from 450 million shares 1,5 years ago to now 1 billion, is staggering. IMO

Go figure.

Good luck to you all you are going to need it

[sentiment_stocks]

Hi Senti, your calculations are way off and total share count is now at 1 billion.

I realize this - as explained in my prior post. I was calculating off a share count of 5 million shares (not 5.5m) AND going off common shares - not preferred. I knew the deal was for preferreds, but was just calculating too quickly and missed that rather large detail.

As stated... this deal looks to be for longs that want to do it. The PR indicates that they have been contacted by shareholders who wanted their opportunity to get both shares and warrants and were unaware or unable to take part in the previous $12 million deal. I believe those deals were for much higher dollar amounts that these are.

This Offering responds to repeated shareholder requests for an opportunity to participate in the Company’s financings on similar terms as the institutional investors and others in those financings. The Company has again been receiving such requests following the recent Series A Preferred Stock financing. The new offering is expected to involve both existing and new investors, targeting those who did not have the opportunity to participate in earlier rounds, with emphasis on long-term holders.

Again... this deal looks to be targeted towards longs who want and can do it. The PR indicates there are shareholders calling indicating they too want such a deal. So now no shareholder can say they weren't offered a similar opportunity.